HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gonadoblastoma in Turner syndrome and Y-chromosome-derived material.

Abstract
The identification of Y-chromosome material is important in females with Ullrich-Turner syndrome (UTS) due to the risk of developing gonadoblastoma or other gonadal tumors. There is controversy regarding the frequency of the Y-chromosome-derived material and the occurrence of gonadoblastoma in these patients. The aim of our study was to evaluate a large number of patients with UTS, followed before and during the pubertal age for the prevalence of Y-chromosome derived material, the occurrence of gonadoblastoma, and the incidence of possible neoplastic degeneration. An unselected series of 171 patients with UTS (1-34 years old), diagnosed cytogenetically, was studied for Y-chromosome markers (SRY and Y-centromeric DYZ3 repeats). The follow-up was of 2-22 years; 101 of these patients were followed during pubertal age. Y-chromosome material was found in 14 patients (8%): 12 of these were gonadectomized (2.8-25.9 years). A gonadoblastoma was detected in four patients under 16 years of age: in two, Y-material was detected only at molecular analysis (at conventional cytogenetic analysis, one was included in the 45,X group and one in the X + mar group) and one had also an immature teratoma and an endodermal sinus carcinoma. The prevalence of gonadoblastoma in our series of gonadectomized UTS patients with Y-positive material was of 33.3% (4/12). Our data suggest that the age of appearance and the possibility of malignant degeneration of gonadoblastoma can occur early in life. These patients, in particular those with 45,X or a marker chromosome may benefit from molecular screening to detect the presence of Y-chromosome material; PCR is a rapid and inexpensive technique. At the moment, laparoscopy and preventive gonadectomy performed as soon as possible remain the procedures of choice for patients with UTS, when Y-chromosome has been identified, as we are still unable to predict a future malignant evolution of gonadoblastoma.
AuthorsLaura Mazzanti, Alessandro Cicognani, Lilia Baldazzi, Rosalba Bergamaschi, Emanuela Scarano, Simona Strocchi, Annalisa Nicoletti, Francesca Mencarelli, Mariacarla Pittalis, Antonino Forabosco, Emanuele Cacciari
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 135 Issue 2 Pg. 150-4 (Jun 01 2005) ISSN: 1552-4825 [Print] United States
PMID15880570 (Publication Type: Journal Article)
CopyrightCopyright (c) 2005 Wiley-Liss, Inc.
Chemical References
  • Genetic Markers
Topics
  • Adolescent
  • Adult
  • Analysis of Variance
  • Centromere (genetics)
  • Chi-Square Distribution
  • Child
  • Child, Preschool
  • Chromosomes, Human, Y (genetics)
  • Female
  • Genes, sry (genetics)
  • Genetic Markers (genetics)
  • Gonadoblastoma (complications, diagnosis, surgery)
  • Humans
  • In Situ Hybridization, Fluorescence
  • Infant
  • Karyotyping
  • Linear Models
  • Ovarian Neoplasms (complications, diagnosis, surgery)
  • Repetitive Sequences, Nucleic Acid (genetics)
  • Turner Syndrome (complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: